Form 13F-HR HS Management Partners, For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 8-K Xeris Biopharma Holdings For: Aug 06
☐000186709600018670962026-08-062026-08-06UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): August 6, 2026XERIS BIOPHARMA HOLDINGS, INC. (Exact name of registrant as specified in its charter)Delaware001-4088087-1082097(State or other jurisdiction ofincorporation)(CommissionFile Number)(I.R.S.... (continue reading...)
Form 8-K Sionna Therapeutics, For: Aug 06
0002036042FALSE00020360422026-08-062026-08-06UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549__________________________FORM 8-K__________________________CURRENT REPORTPursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934Date of Report (date of earliest event reported): August 06, 2026__________________________SIONNA THERAPEUTICS, INC.(Exact name of registrant as specified in its charter)__________________________Delaware001-42504... (continue reading...)
Form 8-K IRONWOOD PHARMACEUTICALS For: Aug 06
false
0001446847
0001446847
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to
Section 13 or 15(d) of the
Form 8-K Tarsus Pharmaceuticals, For: Aug 05
0001819790FALSE00018197902026-08-052026-08-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_______________FORM 8-K CURRENT REPORTPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934Date of Report (date of earliest event reported) August 5, 2026 _______________TARSUS PHARMACEUTICALS, INC.(Exact name of registrant as specified in its charter)_______________Delaware001-3961481-4717861(State or other jurisdiction of incorporation)... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q Cullinan Therapeutics, For: Jun 30
-
Form 8-K CareCloud, Inc. For: Aug 06
-
Form 8-K Bausch & Lomb Corp For: Aug 05
-
Form 8-K Scholar Rock Holding For: Aug 06
-
Form 8-K REGENXBIO Inc. For: Aug 06
-
Form 10-Q TIC Solutions, Inc. For: Jun 30
-
Form 13F-NT Fullerton Fund Investmen For: Jun 30
-
Form 10-Q Monte Rosa Therapeutics, For: Jun 30
-
Form 10-Q Commerce.com, Inc. For: Jun 30
-
Form 10-Q Vistance Networks, Inc. For: Jun 30
-
Form 13F-HR AMF Tjanstepension AB For: Jun 30
-
Form 10-K OPEN TEXT CORP For: Jun 30
-
Form 10-Q Korro Bio, Inc. For: Jun 30
-
Form 8-K Tarsus Pharmaceuticals, For: Jul 31
-
Form 13F-NT Evans Investments Pte. For: Jun 30
-
Form 8-K SharonAI Holdings Inc. For: Aug 06
-
Form 8-K TELEFLEX INC For: Aug 06
-
Form 6-K ATS Corp /ATS For: Jun 28
-
Form 10-Q Core Natural Resources, For: Jun 30
-
Form 8-K Datadog, Inc. For: Aug 06
-
Form 8-K Vistance Networks, Inc. For: Aug 06
-
Form 13F-NT Esta Investments Pte. For: Jun 30
-
Form 6-K AXIA Energia S.A. For: Jun 30
-
Form 8-K OPEN TEXT CORP For: Aug 06
-
Form 8-K Commerce.com, Inc. For: Aug 06
-
Form 8-K Vistance Networks, Inc. For: Aug 04
-
Form 8-K Cullinan Therapeutics, For: Aug 06
-
Form 8-K Zoetis Inc. For: Aug 06
-
Form 8-K Smith Douglas Homes Corp For: Aug 06
-
Form SC TO-T Forte Biosciences, Inc. Filed by: ARGENX SE
-
Form 8-K Shift4 Payments, Inc. For: Aug 06
-
Form 10-Q TripAdvisor, Inc. For: Jun 30
-
Form 8-K Core Natural Resources, For: Aug 06
-
Form 10-Q Cartesian Therapeutics, For: Jun 30
-
Form 13F-NT Ellington Investments For: Jun 30
-
Form 8-K BENTLEY SYSTEMS INC For: Aug 06
-
Form 8-K Resolute Holdings Manage For: Aug 06
-
Form 6-K Pony AI Inc. For: Aug 06
-
Form 8-K Vital Farms, Inc. For: Aug 03
-
Form 13F-HR Marcho Partners LLP For: Jun 30
-
Form 10-Q PAPA JOHNS INTERNATIONAL For: Jun 28
-
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 06
-
Form 10-Q Immunocore Holdings plc For: Jun 30
-
Form 8-K BlackSky Technology Inc. For: Aug 06
-
Form 8-K Tecnoglass Holdings Inc. For: Aug 06
-
Form 8-K Viridian Therapeutics, For: Aug 06
-
Form 8-K LIGAND PHARMACEUTICALS For: Aug 06
-
Form 10-Q CPI Card Group Inc. For: Jun 30
-
Form 8-K Opus Genetics, Inc. For: Aug 06
-
Form 8-K Warner Bros. Discovery, For: Aug 06
